Literature DB >> 23130932

EDIM-TKTL1 blood test: a noninvasive method to detect upregulated glucose metabolism in patients with malignancies.

Oliver Feyen1, Johannes F Coy, Vikas Prasad, Ralf Schierl, Joerg Saenger, Richard P Baum.   

Abstract

AIM: To determine whether the TKTL1 protein epitope detection in monocytes (EDIM) test allows detection of upregulated glucose metabolism in malignancies. MATERIALS &
METHODS: The EDIM-TKTL1 blood test was conducted in 240 patients with 17 different confirmed or suspected malignancies. Test scores were compared with (18)F-fluoro-2-deoxy-D-glucose (FDG)-PET/computed tomography (CT) results.
RESULTS: EDIM-TKTL1 score and FDG-PET results showed a concordance of 90% with a sensitivity of 94% and specificity of 81%. Including CT data, all values were enhanced. A subgroup analysis of non-small-cell lung cancer patients showed a significant correlation between the EDIM-TKTL1 score and the primary tumor size determined by FDG-PET/CT.
CONCLUSION: EDIM-TKTL1 blood test revealed good concordance with FDG-PET/CT results in patients with malignancies demonstrating its efficacy to detect upregulation of glucose metabolism in primary tumors or metastases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23130932     DOI: 10.2217/fon.12.98

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  14 in total

1.  Evaluation of a biomarker based blood test for monitoring surgical resection of oral squamous cell carcinomas.

Authors:  Martin Grimm; Wiebke Kraut; Sebastian Hoefert; Michael Krimmel; Thorsten Biegner; Peter Teriete; Marcel Cetindis; Joachim Polligkeit; Susanne Kluba; Adelheid Munz; Siegmar Reinert
Journal:  Clin Oral Investig       Date:  2015-07-08       Impact factor: 3.573

2.  Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue.

Authors:  Martin Grimm; Oliver Feyen; Heiko Hofmann; Peter Teriete; Thorsten Biegner; Adelheid Munz; Siegmar Reinert
Journal:  Tumour Biol       Date:  2015-10-16

3.  Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma.

Authors:  Edward Sanders; Svenja Diehl
Journal:  Oncoscience       Date:  2015-02-17

4.  Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.

Authors:  Martin Grimm; Sebastian Hoefert; Michael Krimmel; Thorsten Biegner; Oliver Feyen; Peter Teriete; Siegmar Reinert
Journal:  Oral Maxillofac Surg       Date:  2016-02-13

5.  Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells.

Authors:  Aparna Jayachandran; Pu-Han Lo; Anderly C Chueh; Prashanth Prithviraj; Ramyar Molania; Mercedes Davalos-Salas; Matthew Anaka; Marzena Walkiewicz; Jonathan Cebon; Andreas Behren
Journal:  BMC Cancer       Date:  2016-02-22       Impact factor: 4.430

6.  Evaluation of TKTL1 as a biomarker in serum of prostate cancer patients.

Authors:  Igor Tsaur; Kristina Thurn; Eva Juengel; Elsie Oppermann; Karen Nelson; Christian Thomas; Georg Bartsch; Gerhard M Oremek; Axel Haferkamp; Peter Rubenwolf; Roman A Blaheta
Journal:  Cent European J Urol       Date:  2016-06-30

7.  The development of tumours under a ketogenic diet in association with the novel tumour marker TKTL1: A case series in general practice.

Authors:  Natalie Jansen; Harald Walach
Journal:  Oncol Lett       Date:  2015-11-16       Impact factor: 2.967

Review 8.  EDIM-TKTL1/Apo10 Blood Test: An Innate Immune System Based Liquid Biopsy for the Early Detection, Characterization and Targeted Treatment of Cancer.

Authors:  Johannes F Coy
Journal:  Int J Mol Sci       Date:  2017-04-20       Impact factor: 5.923

9.  A key role for transketolase-like 1 in tumor metabolic reprogramming.

Authors:  Santiago Diaz-Moralli; Esther Aguilar; Silvia Marin; Johannes F Coy; Mieke Dewerchin; Maciek R Antoniewicz; Oscar Meca-Cortés; Leen Notebaert; Bart Ghesquière; Guy Eelen; Timothy M Thomson; Peter Carmeliet; Marta Cascante
Journal:  Oncotarget       Date:  2016-08-09

10.  A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells.

Authors:  Martin Grimm; Steffen Schmitt; Peter Teriete; Thorsten Biegner; Arnulf Stenzl; Jörg Hennenlotter; Hans-Joachim Muhs; Adelheid Munz; Tatjana Nadtotschi; Klemens König; Jörg Sänger; Oliver Feyen; Heiko Hofmann; Siegmar Reinert; Johannes F Coy
Journal:  BMC Cancer       Date:  2013-12-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.